GlassScriptPhysician profile
Irfan Waheed
NPI 1841588381
$13,447.19
in general payments reported to CMS, 2019-2025
52 companies · $2,419 in 2025
The $2,419 reported for 2025 was more than what 79% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,105 · 2020: $542 · 2021: $888 · 2022: $1,548 · 2023: $2,644 · 2024: $4,301 · 2025: $2,419.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,168 · Education: $3,086 · Travel and Lodging: $2,111.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,167.85 |
| Education | $3,085.72 |
| Travel and Lodging | $2,110.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,233.48 | 2023-2025 | Da Vinci Surgical System |
| Astrazeneca Pharmaceuticals LP | $1,410.56 | 2019-2025 | Fasenra, Airsupra, Breztri |
| Glaxosmithkline, LLC. | $770.80 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Insmed, INC. | $675.68 | 2021-2025 | Arikayce, Brinsupri |
| Janssen Pharmaceuticals, INC | $607.43 | 2019-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $577.02 | 2019-2025 | Jardiance, Ofev, Spiriva Respimat |
| Boston Scientific Corporation | $491.38 | 2020-2025 | Ekosonic, Eluvia, Cds - Mct/Cem Monitoring |
| Grifols USA, LLC | $291.74 | 2019-2025 | Prolastin-C Liquid |
| Actelion Pharmaceuticals US, INC. | $289.57 | 2019-2023 | Opsumit, Uptravi |
| Merck Sharp & Dohme LLC | $270.73 | 2022-2025 | Zerbaxa, Winrevair, Recarbrio |
| Regeneron Healthcare Solutions, INC. | $243.80 | 2020-2025 | Dupixent |
| Genzyme Corporation | $226.76 | 2020-2025 | |
| Mylan Specialty L.P. | $189.65 | 2019-2024 | Yupelri |
| La Jolla Pharmaceutical Company | $153.34 | 2021-2025 | Giapreza |
| Electromed, INC. | $136.74 | 2021-2023 | Smartvest |
Show all 52 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $128.34 | 2021-2022 | |
| Verona Pharma, INC. | $121.31 | 2025 | Ohtuvayre |
| Circassia INC. | $113.75 | 2019-2020 | |
| Abbvie INC. | $112.95 | 2021-2023 | Avycaz |
| Genentech USA, INC. | $102.29 | 2019-2020 | |
| Viatris Specialty LLC | $94.24 | 2025 | Yupelri |
| United Therapeutics Corporation | $94.19 | 2022-2025 | Tyvaso, Tyvaso |
| Inari Medical, INC. | $89.27 | 2022 | |
| Baxter Healthcare | $82.53 | 2022-2025 | Hillrom - Carnation Ambulatory Monitor, Hillrom - Vest System Model 105 Home Care |
| Abiomed | $78.28 | 2024-2025 | Impella |
| Veran Medical Technologies, INC. | $68.00 | 2021 | |
| Amgen INC. | $64.80 | 2022-2025 | Tezspire |
| Shockwave Medical, INC | $64.60 | 2021-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Pfizer INC. | $59.16 | 2023-2025 | |
| Mallinckrodt Hospital Products INC. | $54.42 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $51.04 | 2025 | Eliquis, Camzyos |
| Jazz Pharmaceuticals INC. | $38.02 | 2025 | |
| Teva Pharmaceuticals USA, INC. | $37.67 | 2021-2022 | |
| Livanova USA, INC. | $36.08 | 2022-2023 | Lifesparc |
| Alnylam Pharmaceuticals INC. | $35.97 | 2024-2025 | Onpattro |
| Mayne Pharma Commercial LLC | $35.08 | 2019-2021 | |
| Philips North America LLC | $29.83 | 2024 | (Ak6) Vest Therapy |
| Ceribell, INC. | $29.66 | 2025 | Pocket Eeg Device |
| Advanced Respiratory, INC | $24.36 | 2019-2020 | |
| Axsome Therapeutics, INC. | $22.67 | 2023 | Sunosi |
| Atricure, INC. | $21.88 | 2022 | |
| Ambu INC. | $21.73 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.85 | 2025 | |
| Kiniksa Pharmaceuticals International, Plc | $18.87 | 2024 | Arcalyst |
| Novo Nordisk INC | $17.94 | 2024 | Ozempic, Rybelsus |
| Allergan, INC. | $17.25 | 2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $16.82 | 2022 | |
| Csl Behring | $16.51 | 2025 | Kcentra |
| Sunovion Pharmaceuticals INC. | $16.11 | 2019 | |
| Fisher & Paykel Healthcare INC | $15.64 | 2022 | |
| Chiesi USA, INC. | $14.09 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $12.31 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Irfan Waheed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.